The emerging therapy of the medication represents a major advance in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide505834.blogofchange.com/42687121/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment